Ravulizumab Antibody

SKU: orb1980577

Description

Ravulizumab (ALXN1210) is a humanized monoclonal antibody that binds with high affinity to complement protein C5, inhibiting terminal complement activation. It is applied in research models of paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, and myasthenia gravis, supporting both in vitro mechanistic studies and in vivo preclinical investigations.

Research Area

Immunology & Inflammation

Images & Validation

−

Tested Applications	ELISA, FC

Key Properties

−

Antibody Type	Inhibitor Antibody
Clonality	Monoclonal
Isotype	Human IgG2 kappa
Target	Complement C5
Molecular Weight	145.80 kDa
Purity	>95% (May vary between batches)
Endotoxin	<1.0 EU/mg
Conjugation	Unconjugated

Storage & Handling

−

Storage	Store at -20°C in small aliquots to prevent freeze-thaw cycles.
Form/Appearance	Liquid
Expiration Date	12 months from date of receipt.
Disclaimer	For research use only

Alternative Names

−

Ravulizumab, ALXN 1210, ALXN1210, ALXN-1210, Complement System, Complement C5, ComplementSystem

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

Quick Database Links

Gene Symbol

Complement C5

UniProt

P01031

UniProt Details

−

No UniProt data available

Documents Download

Datasheet

Product Information

Download

Request a Document

Protocol Information

Flow Cytometry

View Protocol

ELISA

Enzyme-linked Immunosorbent Assay (EIA)

View Protocol

Find More Protocols